Roundhill Investments plans to launch a GLP-1 drug-focused fund in May and has introduced leveraged and inverse ETFs, MAGX and MAGQ, tracking widely held tech stocks.
Roundhill Investments plans to launch a GLP-1 drug-focused fund in May, and already introduced leveraged and inverse ETFs tracking widely held tech stocks, such as MAGX and MAGQ. MAGX aims to profit from the "Magnificent Seven" (Alphabet, Amazon, Apple, Meta Platforms, Microsoft, Nvidia, Tesla) while MAGQ allows betting against them. Both funds reset daily, making them risky for long-term investments.
March 23, 2024
5 Articles